Black Men And Prostate Cancer: A Clue
Feb-25-2007
Compared with white men, African American men are 50 percent more likely to develop prostate cancer, and twice as likely to die from it. They also tend to develop it at younger ages. Like other cancer genetics researchers, Matthew Freedman figured at least part of the explanation for this disparity must lie in the DNA. After all, defective genes that increased breast-cancer risk had been isolated in women, so it was reasonable to assume the equivalent was at work in prostate cancer. It turns out, Freedman said last week, that genetic predisposition to prostate cancer is much more complicated. Speaking at a Wistar Institute symposium on African American men and prostate cancer, Freedman explained how he and his colleagues at Dana Fa...
OHSU Cancer Institute Researcher Identifies Protein Marker For Prostate Cancer Survival
Feb-25-2007
PORTLAND -- An Oregon Health & Science University Cancer Institute researcher has identified a protein that is a strong indicator of survival for men with advanced prostate cancer. The C-reactive protein, also known as CRP, is a special type of protein produced by the liver that is elevated in the presence of inflammation. "This could mean that a simple blood test that is already available could help patients and doctors make better decisions as they become more informed about what to expect from the prostate cancer they are facing," said Tomasz Beer, M.D., director of the Prostate Cancer Research at the OHSU Cancer Institute, associate professor of medicine, (hematology/medical oncology) OHSU School of Medicine. Bee...
New Clinical Data For PROSTASCINT(R) And QUADRAMET(R) In Prostate Cancer Presented
Feb-25-2007
ORLANDO -- Cytogen Corporation today reported that clinical investigators from leading cancer research centers presented data from recent and ongoing clinical trials of both PROSTASCINT(R) (capromab pendetide) and QUADRAMET(R) (samarium Sm-153 lexidronam injection) in prostate cancer at the 2007 Prostate Cancer Symposium, multidisciplinary meeting co-sponsored by the American Society of Clinical Oncology (ASCO), the American Society for Therapeutic Radiology and Oncology (ASTRO), and the Society of Urologic Oncology (SUO) held February 22-24, 2007 in Orlando, Florida. The six PROSTASCINT-related presentations were highlighted by two studies that evaluated the outcomes of prostate cancer patients based on the image findings...
(((prostate cancer treatment) AND "2005/11/13 17.56"[MHDA]:"2115/11/20 14.01"[MHDA])) NOT (( (((prostate cancer[TIAB] AND treatment[TIAB]))) AND "0001"[EDAT]:"2005/11/13 17.56"[EDAT])); +1986 new citations
Feb-27-2007
1986 new PubMed citations were retrieved for your search. Click on the search hyperlink below to display the complete search results:
(((prostate cancer treatment) AND "2005/11/13 17.56"[MHDA]:"2115/11/20 14.01"[MHDA])) NOT (( (((prostate cancer[TIAB] AND treatment[TIAB]))) AND "0001"[EDAT]:"2005/11/13 17.56"[EDAT]))
These PubMed results were generated on 2007/02/27
PubMed, a service of the National Library of Medicine, includes over 15 million citations for biomedical articles back to the 1950's. These citations are from MEDLINE and additional life science journals. PubMed includes links to many sites providing full text articles and other related resources.
Prostate Cancer Therapy May Increase Risk Of Death From Heart Disease In Older Men
Feb-28-2007
Main Category: Prostate / Prostate Cancer News Article Date: 28 Feb 2007 - 8:00 PST Androgen deprivation therapy - one of the most common treatments for prostate cancer - may increase the risk of death from ...
Prostate Cancer Free
Feb-26-2007
TRANSCRIPT FRANK FOWLER SPENT MOST OF HIS LIFE IN THE NAVY. WHEN HE WAS DIAGNOSED WITH PROSTATE CANCER, HE VOWED, LIKE WITH ANY OTHER ENEMY, THAT HE'D FIGHT BACK AND WIN.
Oral Satraplatin as Second-Line Therapy in Advanced Prostate Cancer
Feb-27-2007
The investigation drug satraplatin significantly reduced the risk for disease progression in a phase 3 trial in patients with advanced prostate cancer no longer responding to hormonal therapy or chemotherapy.
Medscape Medical News
Zosia Chustecka
Medscape Medical News
Zosia Chustecka
Tests may spot most deadly prostate cancers
Feb-26-2007
Physicians may soon be able to identify which men have a more deadly form of prostate cancer, U.S. researchers report.
Men's Health: Most With Low-Risk Prostate Cancer Choose Treatment
Feb-25-2007
Men with prostate cancer in its earliest stage have a tough choice: Treat the disease, even though it may never progress to be a health threat, or wait and monitor it for signs that it's spreading. Despite a low risk of spread and the potential unpleasantness of surgery, radiation therapy, or chemo, a new study finds that only a small fraction of eligible men opt for so-called watchful waiting.
Toremifene May Counter Adverse Effects of Hormone Treatment for Prostate Cancer
Feb-27-2007
Emerging data from an ongoing trial in prostate cancer suggest that toremifene may counter the adverse effects that androgen deprivation therapy has on bone and lipid profiles.
Medscape Medical News
Zosia Chustecka
Medscape Medical News
Zosia Chustecka
Green tea and COX-2 inhibitors combine to slow growth of prostate cancer
Feb-28-2007
Drinking a nice warm cup of green tea has long been touted for its healthful benefits, both real and anecdotal. But now researchers have found that a component of green tea, combined with low doses of a COX-2 inhibitor, could slow the spread of human prostate cancer.
Scientists tout new prostate cancer test
(AP)
Feb-27-2007
AP - Oregon scientists say a simple test can identify men at high risk of life-threatening prostate cancer even after a biopsy finds no signs of it. The key, researchers say, is "PSA density," which compares the size of a man's prostate with his levels of a cancer-related protein called prostate-specific antigen.
C-Reactive Protein Could Predict Prognosis in Advanced Prostate Cancer
Feb-26-2007
A readily available blood test for CRP could be a useful for predicting prognosis in advanced prostate cancer.
Medscape Medical News
Zosia Chustecka
Medscape Medical News
Zosia Chustecka
Feb. 25, 2007
Feb-26-2007
One of the most common treatments for prostate cancer may give older patients an increased risk of death from heart disease.
Breast cancer drug could help prostate patients
Feb-25-2007
A breast cancer drug could help men with prostate cancer avoid some dangerous side effects of treatment, a study shows.
Cancer, Preventing Prostate Cancer
Feb-22-2007
Prostate cancer is one of the most common forms of cancer in men In fact only skin cancer is more common Over 200 000 men will be diagnosed with prostate cancer this year and one in six men will be diagnosed with the disease during their lifetime But there is some good news about prostate cancer too Of the one in six men who will be diagnosed with prostate cancer only one in 34 will die from the disease And death rates from prostate cancer are declining because of earlier detection and better treatments Prostate cancer is usually a slow growing form of cancer making it an excellent target for prevention Who Gets Prostate Cancer While doctors don amp rsquo t fully understand exactly what causes prostate cancer there are some risk factors that do increase a man amp rsquo s likelihood of developing this disease
New Treatments Prostate Cancer, Prostate Cancer Survival Rates
Feb-18-2007
There are approximately 25 000 men newly diagnosed with prostate cancer every year in the United Kingdom For these men the risk of dying from their prostate cancer depends on a number of risk factors For example if the cancer is confined to the prostate gland at diagnosis the chance of surviving to 5 years is 70 If the cancer has already spread e g to the bones then only 20 of men will survive to five years Of all the men who currently have prostate cancer in the UK approximately 10 000 will die of the disease each year The prostate cancer survival rate is much higher in the developed world unsurprisingly When a man is first diagnosed with prostate cancer then the doctor who has found the cancer most often a amp 8220 urologist amp 8221 amp 8212 a surgeon who specialises in looking after problems to do with the kidneys prostate and bladder will arrange a series of tests to help assess the risk for that individual patient The results of these tests will in turn help the doctor and patient to decide the best treatment for that patient
Research From University Of California Sheds Light On Prostate Cancer
Feb-18-2007
Research conducted from University of California, U.S., has updated our knowledge about prostate cancer. Study 1: Fresh data on prostate cancer are presented in the report "Religious coping and problem-solving by couples faced with prostate cancer." According to a study from the United States, "Religion can be an important resource for people struggling with chronic illness. Problem-solving skills have also been shown to be helpful." "This study examined whether turning to religion as a coping resource would be associated with better problem-solving in couples trying to manage challenges associated with prostate cancer. The sample was 101 patients with prostate cancer and their wives. Wives completed the Social Problem-Solving Invento...
New Study Shows Cough Medicine Effective Against Prostate Cancer
Feb-18-2007
DOVER, Del. -- A presentation made at the 17th International Prostate Cancer Update Conference in Vail, Colorado, has shown noscapine to be effective against prostate cancer. Noscapine, a non-addictive derivative of opium, has been used worldwide since the 1950's as an anti-cough medication. Noscapine was originally proposed as an anti-cancer agent in the early 1960's. However major studies of its broad anti-cancer effects were only done in recent years. The study in prostate cancer is the result of ongoing collaboration between the Prostate Cancer Research and Educational Foundation (PC-REF) and MedInsight Research Institute. Dr. Israel Barken, Founder and Medical Director of the Prostate Cancer Research and Educat...
Study Results From University Of Miami In The Area Of Prostate Cancer Discussed
Feb-18-2007
New prostate cancer study findings have been reported from University of Miami, U.S. Study 1: Fresh data on prostate cancer are presented in the report "Psychosocial and sociodemographic correlates of benefit-finding in men treated for localized prostate cancer." According to recent research published in the journal Psycho-Oncology, "Prostate cancer (PCa) treatment involves decrements in quality of life such as decreased sexual functioning and urinary/bowel incontinence." "Prior work in other cancers has identified positive consequences (e.g. personal growth) following diagnosis and treatment, a phenomenon that has been referred to as benefit-finding (BF) and positively related to quality of life. The present study evaluated demograph...
New Treatments For Prostate Cancer
Feb-20-2007
... effects. One way is to reduce the amount of radiation received by normal organs (bladder, bowel etc) and this has been improving over the last few years with better machines and techniques such as ?conformal radiotherapy? and ?IMRT?.
Work is also being carried out on combining brachytherapy with external therapy to allow some of the benefits of brachytherapy (fewer side effects, higher overall dose to the prostate cancer) to be used for men with more advanced prostate cancer without compromising the chance of cure.
NEW HORMONE THERAPY FOR PROSTATE CANCER
Some newer prostate cancer hormone treatments have fewer side effects than older hormone based drugs. Some are also felt to be more effective. All the time researchers are testing to try and find the best hormone tablets or injections...
The Key Facts Behind Prostate Cancer
Feb-20-2007
Prostate cancer is the most commonly diagnosed cancer of UK men. If it is found early and is still confined to the gland itself then the chances of survival are excellent. Modern surgical techniques, combined with drugs such as Viagra, mean that an operation to treat prostate cancer does not signal the end of a patient's sex-life. The prostate itself is a small, walnut-sized gland situated near the bladder in men that produces one component of semen. There are a broad range of prostate cancers, ...
Variation In The Definition Of Biochemical Recurrence In Patients Treated For Localized Prostate Cancer
Feb-19-2007
UroToday.com- One of the problems with prostate cancer outcomes studies is the lack of standardization in the definition of "treatment failure". While after radical prostatectomy most experts would agree that a serum PSA concentration greater than 0.2 ng/ml constitutes a recurrence, some institutions use 0.1 ng/ml and others use 0.4 ng/ml. [click link for full article]
Body Mass Index, Weight Change, And Risk Of Prostate Cancer In The Cancer Prevention Study II Nutrition Cohort
Feb-19-2007
UroToday.com- In the last five years, a large body of evidence has been accumulated supporting the association between obesity and high-risk prostate cancer. Despite this advancement in our knowledge of prostate carcinogenesis, the exact interplay between BMI and patient risk remains poorly understood. [click link for full article]
New drugs show promise for prostate cancer
Feb-19-2007
U.S. oncologists say a new class of targeted anti-cancer drugs shows promise in prolonging the lives of patients with recurrent prostate cancer.
New Drugs Show Promise For Prostate Cancer
Feb-20-2007
U.S. oncologists say a new class of targeted anti-cancer drugs shows promise in prolonging the lives of patients with recurrent prostate cancer....
Tests May Spot Most Deadly Prostate Cancers
Feb-22-2007
Title: Tests May Spot Most Deadly Prostate Cancers
Category: Health News
Created: 2/23/2007 2:00:00 AM
Last Editorial Review: 2/23/2007
Category: Health News
Created: 2/23/2007 2:00:00 AM
Last Editorial Review: 2/23/2007
Prostate Cancer Overtreated?
Feb-22-2007
Title: Prostate Cancer Overtreated?
Category: Health News
Created: 2/23/2007
Last Editorial Review: 2/23/2007
Category: Health News
Created: 2/23/2007
Last Editorial Review: 2/23/2007
Parenteral oestrogens for prostate cancer
Feb-20-2007
The purpose of this review was to examine the literature on the use of parenteral oestrogens (e.g.
administered intravenously, intramuscularly, subcutaneously or transdermally) in prostate cancer, in
order to inform the design of a randomised clinical trial. [CRD Report 33]
Bill pitches free prostate cancer tests
Feb-21-2007
The proposal would require all health insurers in the state to pay for physical exams and blood tests to detect prostate cancer.
Prostate Cancer Therapy May Increase Risk Of Death From Heart Disease In Older Men
Feb-24-2007
Science Daily - Androgen deprivation therapy - one of the most common treatments for prostate cancer - may increase the risk of death from heart disease in patients over age 65, according to a new study by ...
Protox Announces PRX302 Data to Be Presented at ASCO Sponsored Prostate Cancer Symposium
Feb-23-2007
Protox Therapeutics Inc. today announced that additional pre-clinical efficacy and safety data on PRX302, a novel pore-forming targeted toxin, will be presented this week at the Prostate Cancer Symposium, a ...
Tests May Spot Most Deadly Prostate Cancers
Feb-22-2007
Physicians may soon be able to identify which men have a more deadly form of prostate cancer, U.S. researchers report.
Men With Prostate Cancer More Optimistic After Several Years Of Treatment Than At Diagnosis, Reveals Global Survey
Feb-19-2007
Men being treated for prostate cancer feel more optimistic about their condition over time, reflecting their positive experience of treatment and the high level of trust they have in their specialist physician, according to results from a global survey1 providing unique insight into men's experience of this common cancer. [click link for full article]
Tests May Spot Most Deadly Prostate Cancers
(HealthDay)
Feb-22-2007
HealthDay - THURSDAY, Feb. 22 (HealthDay News) -- Physicians may soon be able
to identify which men have a more deadly form of prostate cancer, U.S.
researchers report.
Prostate cancer screenings offered
Feb-22-2007
Gulf Coast Cancer Centers will hold a prostate cancer screening for the public at the Monroeville office, Southwest Alabama Community Cancer Center, on Thursday, March 1 from 11 a.m. to 1 p.m. Gulf Coast Cancer ...
Qualitative Analysis of Couples' Experience With Prostate Cancer by Age Cohort
Feb-20-2007
Findings indicated that similarities and differences exist when couples of different ages deal with prostate cancer.
Cancer nursing
Cancer nursing
Exercise helps in prostate cancer
Feb-23-2007
Exercising improves the quality of life for men being treated with radiation for prostate cancer, according to U.S. researchers.
Prostate cancer therapy may increase risk of death from heart disease in older men
Feb-23-2007
Androgen deprivation therapy -- one of the most common treatments for prostate cancer -- may increase the risk of death from heart disease in patients over age 65, according to a new study by researchers at Dana-Farber Cancer Institute, Brigham and Women's Hospital and other institutions.
Prostate cancer therapy may increase risk of death from heart disease in older men
Feb-24-2007
Androgen deprivation therapy - one of the most common treatments for prostate cancer - may increase the risk of death from heart disease in patients over age 65, according to a new study by researchers at ...
Baptist to perform clinical trial of prostate cancer therapy
Feb-21-2007
A collaboration of Baptist Memorial Health Care Corp. and local urologists is the first group in the nation approved for Phase III clinical trials of a prostate cancer therapy that destroys cancer cells with sound waves.
Protox Reports Promising Interim Results from Prostate Cancer Study
Feb-19-2007
(PharmaLive) VANCOUVER, Jan. 18 /CNW/ - Protox(TM) Therapeutics Inc. (TSX-V:PRX) today announced interim results from its ongoing Phase I clinical trial evaluating PRX302 in patients with localized, recurrent prostate cancer. The findings to date indicate that PRX302 is well tolerated and shows encouraging signs of therapeutic activity following a single intra-prostatic injection.
Antisoma encouraged by cancer drug data
Feb-23-2007
UK biotech firm Antisoma has reported positive interim findings from its ongoing phase II trial of AS1404 in hormone-refractory prostate cancer.
Monroe s Mayor Undergoing Cancer Treatments
Feb-20-2007
The Mayor of the City of Monroe, Michigan has cancer. Mayor Al Cappuccilli , 76, is being treated for prostate cancer.
Radiation information available in Spanish
Feb-23-2007
The American Society for Therapeutic Radiology and Oncology is offering Spanish versions of brochures on radiation therapy for breast and prostate cancer.
Medivation to present early data on cancer drug
Feb-19-2007
Medivation Inc. said it will present preclinical efficacy data on a prostate cancer drug it intends to test in clinical trials later this year.
Researcher identifies men who require second prostate biopsy
Feb-22-2007
Mark Garzotto, M.D., has been invited to present his findings on Thursday, Feb. 22, at the Multidisciplinary Prostate Cancer Symposium in Orlando, Fla.
State treasurer diagnosed with cancer
Feb-20-2007
- State Treasurer Vern Larson said Friday he has been diagnosed with prostate cancer and will have surgery next month.
New Findings In Prostate Cancer Described From The United States
Feb-11-2007
Data on prostate cancer are outlined in reports from the United States. Study 1: A report, "Characteristics of patients with familial versus sporadic prostate cancer," is newly published data in The Journal of Urology. "There are conflicting reports concerning whether prostate cancer in families with multiple affected members has different clinical and pathological features than sporadic cases. In our study we compared the clinical characteristics, pathological outcomes and the 7-year biochemical progression-free rate in patients with apparent sporadic prostate cancer, affected sibling pairs, families with multiple affected members and families meeting the Johns Hopkins criteria for hereditary prostate cancer. From 1983 to 2003, 3,478 me...
New Prostate Cancer Therapy Findings From University Of Virginia Published
Feb-11-2007
Scientists discuss in "Cancer incidence after localized therapy for prostate cancer" new findings in prostate cancer. "Second cancers may occur in patients who have undergone radiation therapy. The risk for these adverse events after therapy is uncertain," researchers in the United States report. "In this study, the authors examined the size and significance of the observed association between occurrences of secondary cancers 5 years after radiotherapy in a large population of men with incident prostate cancer. Men with incident prostate cancer were identified from the Surveillance, Epidemiology, and End Results (SEER) registry and were distinguished by the type of treatment received, tumor stage, tumor grade, and age at diagnosis. SEER...
Death From Below
Feb-12-2007
I was flipping through my latest copy of Triathlete Magazine and came across this ad from Athletes for a Cure. I was shocked by their proclaimed statistic. THIS YEAR, one in six American men will be diagnosed with prostate cancer. Really? So, statistically, every six years every single man in American will be diagnosed with prostate cancer and on average a man will be diagnosed 10 times in his lifetime. Based on their claim, roughly 17 million men will be diagnosed this year. Luckily, none of this is true and it's simply some really bad copy. The one in six statistic is actually over a man's lifetime, not each year. Each year, 218,000 men are diagnosed with prostate cancer, 27,000 will die from it. With early detection and treatment, there is a 90% survival rate. Those are still scary numbers, but it's not the black plague that the ad makes it out to be. If you're interested in donating towards fighting prostate cancer, go to the prostate cancer foundation....
Something on Prostate Cancer
Feb-12-2007
If you have just learned that you have prostate cancer or know someone who has been diagnosed with it, you may be feeling depressed and angry. However such type of cancer can be treated and you can go on living a normal and healthy life again. The treatment of prostate cancer can vary depending on the advancement of the disease, the patients physical state, and other factors. The first signs of Prostate cancer that someone can exhibit can be a difficulty in urinating, which occurs because the p...
CEO makes matching $755K donation
Feb-12-2007
Wade Thompson said last month that he would give one million dollars to prostate cancer research if the same amount were donated by the end of the year to the National Prostate Cancer Coalition.
Surviving prostate cancer : what you need to know to make informed decisions / Torrey, E. Fuller (Edwin Fuller), 1937-
Feb-15-2007
Surviving prostate cancer : what you need to know to make informed decisions / Torrey, E. Fuller (Edwin Fuller), 1937-
Spectrum requests approval of prostate cancer therapy
Feb-16-2007
Spectrum Pharmaceuticals has filed its new drug application to US regulators for satraplatin, its drug candidate for the treatment of hormone refractory prostate cancer for those who have failed chemotherapy.
GTx samples help MacroArray find protein marker for prostate cancer
Feb-14-2007
GTx Inc. has helped another company move down the field in its quest for a cheap, noninvasive test to identify men at risk of developing prostate cancer.
A Genetics Perspective on Prostate Cancer
Feb-15-2007
Both genetic and nongenetic factors contribute to prostate cancer disease initiation and progression.
Urologic nursing : official journal of the American Urological Association Allied
Urologic nursing : official journal of the American Urological Association Allied
New class of targeted cancer drugs shows promise in slowing progression of recurrent prostate cancer
Feb-15-2007
A new class of targeted anti-cancer drugs that blocks the human epidermal growth factor (HER) receptor family shows promise in prolonging the lives of patients with recurrent prostate cancer, a new Cedars-Sinai study shows.
Hall of Fame Tennis Pro Roy Emerson Wins Match and Defeats Prostate Cancer with Expertise of David B Samadi MD and da Vinc
Feb-12-2007
Prostate cancer is the (second) most common cancer diagnosed in American men in fact there are over 220000 new diagnoses each year Roughly half of these men will weigh their options and consider an open radical prostatectomy a surgery requiring removal of......
Hall of Fame Tennis Pro Roy Emerson Wins Match and Defeats Prostate Cancer with Expertise of David B. Samadi, M.D. and da Vinci Robotic Technology
Feb-12-2007
A prostate cancer patient and winner of 28 Grand Slam titles, Roy Emerson, tells his story about his robotic prostatectomy in December. It takes a specialist like David B. Samadi, M.D., to get the most out of what the da Vinci surgical system offers. (PRWeb Feb 12, 2007)
Post Comment:Trackback URL: http://www.prweb.com/pingpr.php/UGlnZy1NYWduLVNpbmctSG9yci1NYWduLVplcm8=
Breakthrough in Pancreatic Cancer
Feb-16-2007
You don?t generally hear much about pancreatic cancer, probably because it isn?t as common as breast, lung or prostate cancers, but perhaps also because there hasn?t been an improvement in...
Senator enlists robotic aid in cancer fight
Feb-17-2007
State Sen. Robert Bunda underwent prostate cancer surgery Feb. 2 in Los Angeles with a robot that doctors are learning to use at the Queen's Medical Center.
Men risk death by avoiding prostate screening
Feb-12-2007
My experience with prostate cancer began in 1994 with the usual getting up three to four times a night to empty my bladder.
Mayor battles cancer again
Feb-12-2007
Mayor Darwin Hindman said he has been diagnosed with early-stage prostate cancer, but he already has begun treatment and expects a full recovery by this spring.
Mayor undergoing cancer treatment
Feb-12-2007
Mayor Darwin Hindman announced at a news conference on Monday that he received treatment for prostate cancer on Feb.
GOODLIFE In the Mid-Hudson Valley
Feb-16-2007
Mariner's Harbor on Broadway in Kingston will be the site on March 15 of the first Floyd Patterson Fund for Prostate Cancer Care fundraiser.
Health Tip: Symptoms of Enlarged Prostate
(HealthDay)
Feb-12-2007
HealthDay - (HealthDay News) -- An enlarged prostate, medically referred to
as benign prostatic hyperplasia (BPH), occurs in most men as they age. It
does not raise your risk for prostate cancer.
Cancer's bias is deadly mystery
Feb-11-2007
Enoch Smith Sr., 77, of Gates arrives at the treatment room at Rochester General Hospital for his regular round of radiation treatment for prostate cancer.
News Index For 2007/02/12
Feb-13-2007
Columbia Mayor Darwin Hindman talks this morning about being diagnosed with prostate cancer, which he said won't affect his decision to run for another term.
In the Region
Feb-16-2007
AKRON: Akron attorney J. Bruce Hunsicker's work to educate men about prostate cancer prompted Leadership Akron to name him its Distinguished Leader Award winner for 2007.
Calcitriol With Docetaxel May Boost Prostate Cancer Survival
Feb-16-2007
A new study suggests the combination therapy may improve survival without increasing the toxicity of docetaxel alone.
Medscape Medical News
Allison Gandey
Medscape Medical News
Allison Gandey
Prostate Cancer Treatment Options: Selecting What Is Best
Feb-04-2007
Being diagnosed with prostate cancer nowadays is by no means a death sentence however it is imperative that you get treatment without delay. There are a number of prostate cancer treatment options available and the best one for you will depend on your individual case. You need to speak with your oncologist and decide what you want to achieve from your prostate cancer treatment so that the right course of treatment can be selected for you.This can initially be quite difficult to do, especially wh...
Radiation Therapy For Prostate Cancer Treatment
Feb-04-2007
Radiation therapy, also commonly known as radiotherapy, is the most frequently prescribed prostate cancer treatment. It is designed to kill off your cancerous cells with high energy radiation beams however even with the accurateness of the process today some normal body cells are inevitably also killed during radiotherapy sessions. This accounts for any side effects you may suffer from. Radiotherapy as a prostate cancer treatment can be used for all stages of the disease. If you are diagnosed as...
Selenium may cut prostate cancer risk in some men
Feb-05-2007
NEW YORK - Despite widespread interest in selenium for warding off prostate cancer, a new study shows that a high blood level of selenium is not in itself generally associated with reduced prostate cancer ...
Selenium may cut prostate cancer risk in some men
Feb-06-2007
NEW YORK (Reuters Health) - Despite widespread interest in selenium for warding off prostate cancer, a new study shows that a high blood level of selenium is not in itself generally associated with reduced prostate cancer risk.
Resistance Training and Reduction of Treatment Side Effects in Prostate Cancer Patients
Feb-09-2007
This study examines the effect of progressive resistance training on muscle function, functional performance, balance, body composition, and muscle thickness in men receiving androgen deprivation for prostate cancer.
Medicine & Science in Sports & Exercise®
Medicine & Science in Sports & Exercise®
Radiation Seed Therapy Fights Prostate Cancer
Feb-05-2007
Prostate cancer patients who receive radiation seed implants, called brachytherapy, have high survival rates, a U.S. study finds.
"Excellent Results" With Implanted Radiation Seeds in Early Prostate Cancer
Feb-08-2007
Pooled data from 11 institutions across the United States confirm excellent long-term results with permanent radiation seed implantation as the sole therapy for early prostate cancer.
Medscape Medical News
Zosia Chustecka
Medscape Medical News
Zosia Chustecka
No answers from Rhodri on Prostate Cancer
Feb-05-2007
In Plenary today Jenny Randerson, Assembly Member for Cardiff Central asked for clarification on whether prostate cancer sufferers would be treated in England while brachytherapy was being introduced to Wales. Jenny also asked whether people from North Wales would be expected to travel down to Cardiff for treatment once it was established.
Prostate Cancer Update on 'Active Surveillance'
Feb-04-2007
Highlights of the International Conference on Active Surveillance for Prostate Cancer will be presented on Tuesday, Feb. 27 from 4 to 5:30 p.m. at , 1600 Divisadero St., in Herbst Hall.
Radiation Seed Therapy Fights Prostate Cancer
(HealthDay)
Feb-05-2007
HealthDay - MONDAY, Feb. 5 (HealthDay News) -- Prostate cancer patients who
receive radiation seed implants, called brachytherapy, have high survival
rates, a U.S. study finds.
Gene Elevating Breast Cancer Risk Also Causes Prostate Cancer
Feb-08-2007
An international multicenter research effort has identified a new genetic defect as a potential heritable breast cancer susceptibility candidate. The same PALB2 mutation also seems to in some measure cause prostate cancer.
Selenium reduces prostate cancer risk in men taking extra vitamin E
Feb-05-2007
A new study is suggesting that for certain groups of men a high dietary intake of selenium may reduce their risk of prostate cancer.
A cancer quandary
Feb-05-2007
Some doctors believe a blood test to screen for prostate cancer saves lives. Others say it has done more harm than good by resulting in unnecessary procedures.
Pertuzumab Ineffective in Hormone-Refractory Prostate Cancer
Feb-05-2007
Results of a phase 2 trial show that not a single patient achieved the primary endpoint of a greater than 50% decline in prostate-specific antigen.
Medscape Medical News
Allison Gandey
Medscape Medical News
Allison Gandey
Freshman legislator Kowalko faces cancer fight
Feb-06-2007
Rep. John Kowalko, D-Newark South, will undergo surgery for prostate cancer Wednesday at Johns Hopkins Hospital in Baltimore.
Cancer treatment trial gets grant
Feb-06-2007
A 28-year journey by a Brisbane scientist has been rewarded with a $500,000 grant to help fund a world-first trial into a lifesaving prostate cancer treatment.
THA to give $.4m in aid to Prostate Cancer Survey
Feb-01-2007
The Tobago House of Assembly is providing $.4 million in financial assistance to the Tobago Prostate Cancer Survey to assist it in increasing the amount and the scope of the research being conducted i...
Schizophrenia tied to low prostate cancer risk
Feb-01-2007
NEW YORK (Reuters Health) - The rate of prostate cancer among men with schizophrenia is lower than in the general population, according to findings published in the journal Urology.
Patients wait for cancer therapy
Feb-01-2007
Campaigners wait to hear when a radiation treatment for prostate cancer is to be offered on the NHS in Wales.